Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Rodgers

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Plos Neglected Tropical Diseases|October 28, 2015
Central Nervous System Parasitosis and Neuroinflammation Ameliorated by Systemic IL-10 Administration in Trypanosoma brucei-Infected MiceJean Rodgers, Barbara Bradley, Peter G E Kennedy, et al.
Plos Neglected Tropical Diseases|March 23, 2019
Safety and efficacy of three trypanocides in confirmed field cases of trypanosomiasis in working equines in The Gambia: a prospective, randomised, non-inferiority trialAlexandra G Raftery, Saloum Jallow, Jean Rodgers, et al.
Journal of Neurochemistry|October 1, 2008
The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brainLisa Sanderson, Murat Dogruel, Jean Rodgers, et al.
Frontiers in Endocrinology|September 24, 2021
Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer TreatmentRachael Jean Rodgers, Jason Anthony Abbott, Kirsty A Walters, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2009
Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated proteinLisa Sanderson, Murat Dogruel, Jean Rodgers, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 9, 2010
The distribution of nifurtimox across the healthy and trypanosome-infected murine blood-brain and blood-cerebrospinal fluid barriersSinthujah Jeganathan, Lisa Sanderson, Murat Dogruel, et al.
The Journal of Antimicrobial Chemotherapy|October 10, 2014
A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasisHollie Burrell-Saward, Jean Rodgers, Barbara Bradley, et al.
Brain : a Journal of Neurology|April 3, 2009
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasisJean Rodgers, Trevor W Stone, Michael P Barrett, et al.
Expert Review of Vaccines|January 30, 2010
DNA vaccines: a rational design against parasitic diseasesJoana A Carvalho, Jean Rodgers, Jorge Atouguia, et al.
Parasites & Vectors|March 23, 2020
Variation in disease phenotype is marked in equine trypanosomiasisAlexandra G Raftery, Saloum Jallow, Robert M Coultous, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Plos Neglected Tropical Diseases|October 28, 2015
Central Nervous System Parasitosis and Neuroinflammation Ameliorated by Systemic IL-10 Administration in Trypanosoma brucei-Infected MiceJean Rodgers, Barbara Bradley, Peter G E Kennedy, et al.
Plos Neglected Tropical Diseases|March 23, 2019
Safety and efficacy of three trypanocides in confirmed field cases of trypanosomiasis in working equines in The Gambia: a prospective, randomised, non-inferiority trialAlexandra G Raftery, Saloum Jallow, Jean Rodgers, et al.
Journal of Neurochemistry|October 1, 2008
The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brainLisa Sanderson, Murat Dogruel, Jean Rodgers, et al.
Frontiers in Endocrinology|September 24, 2021
Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer TreatmentRachael Jean Rodgers, Jason Anthony Abbott, Kirsty A Walters, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2009
Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated proteinLisa Sanderson, Murat Dogruel, Jean Rodgers, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 9, 2010
The distribution of nifurtimox across the healthy and trypanosome-infected murine blood-brain and blood-cerebrospinal fluid barriersSinthujah Jeganathan, Lisa Sanderson, Murat Dogruel, et al.
The Journal of Antimicrobial Chemotherapy|October 10, 2014
A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasisHollie Burrell-Saward, Jean Rodgers, Barbara Bradley, et al.
Brain : a Journal of Neurology|April 3, 2009
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasisJean Rodgers, Trevor W Stone, Michael P Barrett, et al.
Expert Review of Vaccines|January 30, 2010
DNA vaccines: a rational design against parasitic diseasesJoana A Carvalho, Jean Rodgers, Jorge Atouguia, et al.
Parasites & Vectors|March 23, 2020
Variation in disease phenotype is marked in equine trypanosomiasisAlexandra G Raftery, Saloum Jallow, Robert M Coultous, et al.
Pageof 4